ResMed Total Liabilities and Share Holders Equity 2010-2024 | RMD
ResMed total liabilities and share holders equity for the quarter ending September 30, 2024 was $7.222B, a 7.15% increase year-over-year.
- ResMed total liabilities and share holders equity for 2024 was $6.872B, a 1.79% increase from 2023.
- ResMed total liabilities and share holders equity for 2023 was $6.752B, a 32.49% increase from 2022.
- ResMed total liabilities and share holders equity for 2022 was $5.096B, a 7.78% increase from 2021.